Skip to content

The Target-D Study: An individually randomised controlled trial of a clinical prediction tool to triage and target treatment for depressive symptoms in general practice.

The Target-D Study: An individually randomised controlled trial of a clinical prediction tool to triage and target treatment for depressive symptoms in general practice.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12616000537459
Enrollment
1868
Registered
2016-04-27
Start date
2016-04-04
Completion date
2018-01-10
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Up to 55% of patients who see a GP have problems with stress, worries or depression, however it’s not always clear which patients will naturally recover and which ones would benefit from treatment. Researchers from the University of Melbourne have developed the Target-D Toolkit which identifies patients that might benefit from treatment and helps GPs to more effectively manage their patients’ emotional well-being. This study will improve people’s health and well-being and make better use of GPs time at less cost to the healthcare budget. It is funded by the National Health and Medical Research Council (NHMRC No: 1059863).

Interventions

The intervention comprises a systematic risk assessment, feedback and tailored treatment recommendation delivered using the Target-D Toolkit, which was developed by our team using findings from our naturalistic longitudinal cohort study of depression in Australian primary care (the diamond study). The Target-D Toolkit comprises 17 online multiple choice questions and takes about 2 minutes to complete. Patients will be invited to complete the toolkit in their GP waiting room, however GPs are no

The intervention comprises a systematic risk assessment, feedback and tailored treatment recommendation delivered using the Target-D Toolkit, which was developed by our team using findings from our naturalistic longitudinal cohort study of depression in Australian primary care (the diamond study). The Target-D Toolkit comprises 17 online multiple choice questions and takes about 2 minutes to complete. Patients will be invited to complete the toolkit in their GP waiting room, however GPs are not directly involved in toolkit completion. GPs will only become involved in Target-D where patients' toolkit responses indicate they are at high risk of chronic depression, In this case GPs will be informed of the patient's risk group and involved in the delivery of appropriate treatment (see details below). Treatment recommendations are in line with current evidence on best practice for mild, moderate, and severe depression. Participants will complete the Target-D Toolkit on a purpose-built secure website and be triaged into low, medium, or high risk of chronic depression. The low risk group will be offered self-help and automated follow-up using the myCompass internet based Cognitive Behavioural Therapy (iCBT) program which has been proven to be effective in reducing depressive symptoms and improving functioning in low risk individuals. myCompass is an interactive self-help internet resource consisting of information, accounts of others’ experiences, treatment modules with home tasks, and mood tracking functions. In line with standard myCompass recommendations, participants are encouraged to complete at least 2 modules over 8 weeks, but ultimately are free to use the myCompass program as much or as little as they like. Each module comprises three online lessons which take about 10-15 minutes. myCompass users are instructed to leave a week between each online lesson to complete home tasks and practice skills. myCompass encourages adherence with regular reminder texts and emails and collects information on the number of visits, modules completed, and moods tracked. The medium risk group will be offered guided iCBT via the ThisWayUp program, which has been shown in several RCTs to be effective in reducing moderate symptoms of depression. ThisWayUp comprises six structured online lessons using CBT principles and includes lessons in the form of an illustrated story about someone with depression, printable summaries extra resources, and homework assignments, symptom monitoring, and vignettes written recovery stories by previous users about their own experiences. Lessons are completed in a linear order. Each lesson takes about 20 minutes to complete, and can be completed in one or multiple sittings. Each lesson is unlocked 5 days after the previous lesson has been completed, in order to allow time for patients to complete homework tasks. Participants are encouraged to complete the entire six-lesson course in 8 weeks. This Way Up patients receive weekly phone calls of approximately 10 minutes from a trained research assistant, providing support and encouragement to continue with the program. The system collects data on the frequency and duration of use and lessons completed. The high risk group will be offered collaborative care, which is an enhanced form of patient care shown to be effective for treatment of moderate to severe depression in primary care. Key features of collaborative care include: provision of a trained case manager, who will develop a structured evidence based care plan with the participant; scheduled follow-ups and monitoring; and co-ordinated communication between health professionals involved in management. Patients will attend 8 sessions with their case manager over 12 weeks (weekly for the first 4 sessions and fortnightly thereafter). Case managers are qualified nurses. Other health professionals involved in care may involve mental health nurses, social workers, psychologists, or psychiatrists, as appropriate to the patient's needs. Patients will be referred to these professionals through normal processes. The evidence-based care plan meets the requirements of the Medicare mental health treatment plan, allowing subsidised access to mental health specialists through the Better Access program. It includes an assessment of patient history and current symptoms. It assists patients to identify their main concerns, and set goals in these areas. Nurses will provide psychoeducation and suggest appropriate treatments to patients as necessary. The nurse will provide a copy of the care plan to the patient's GP and discuss as appropriate. Patients will then see their GP for finalisation of the care plan and referrals and prescriptions where required. Ultimately, the GP retains responsibility for the patient's care and his or her role therefore is to review the care plan drafted by the patient and nurse and finalise as appropriate. Treatment adherence will be monitored by the nurse in the 7 follow-up appointments.

Sponsors

University of Melbourne
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Aged between 18 and 65 years old * PHQ-2 score of 2 or more * Regular access to a computer with internet * Able to comply with study intervention and assessments (ie. sufficient English and reading skills) * If taking antidepressant medication, at least 1 month with the same medication

Exclusion criteria

* Currently taking antipsychotic medication * Currently seeing or looking to see a psychologist in the next 3 months * Currently accessing iCBT

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 24, 2026